Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis

Scandinavian Journal of Rheumatology

Volumn 29, Issue 2, 2000, Pages 95-102

  Vencovský, Jiří ^a,c   Jarosova K ^a   Machacek S ^a   Studynkova J ^a   Kafkov J ^a   Bartunkov J ^a   Nemcova D ^b   Charvat F ^a  

^a CENTRAL MILITARY HOSPITAL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

Cyclosporine A; Dermatomyositis; Methotrexate, IL 1Ra; Polymyositis; Treatment

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; CREATINE KINASE; CYCLOSPORIN A; INTERLEUKIN 1 RECEPTOR; METHOTREXATE; MYOGLOBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; MALE; MUSCLE EXERCISE; POLYMYOSITIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033935721     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097400750001897     Document Type: Article

References (37)

1. 1. Bunch TW, Worthington JW, Combs JJ, Ilstrup DM, Engel AG. Azathioprine with prednisone for polymyositis. Ann Intern Med 1980;92:365-9.
2. 2. Bunch TW. Prednisone and azathioprine for polymyositis. Arthritis Rheum 1981;24:45-8.
3. 3. Miller FW, Leitman SF, Cronin ME, Hicks JE, Leff RL, Wesley R, et al. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992;326:1380-4.
4. 4. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993 2000.
5. 5. Villaba L, Hicks JE, Adams EM, Sherman JB, Gourley MF, Leff RL, et al. Treatment of refractory myositis. Arthritis Rheum 1998;41:392-9.
6. 6. Joffe MM, Love LA, Leff RL, Fraser DD, Targoff IN, Hicks JE, et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 1993;94:379-87.
7. 7. Villaba L, Adams EM. Update on therapy for refractory dermatomyositis and polymyositis. Curr Opin Rheumatol 1996;8:544-51.
8. 8. Mastaglia FL, Phillips BA, Zilko P. Treatment of inflammatory myopathies. Muscle Nerve 1997;20:651-64.
9. 9. Zieglschmid-Adams ME, Pandya AF, Cohen SB, Sontheimer RD. Treatment of dermatomyositis with methotrexate. J Am Acad Dermatol 1995;32:754-7.
10. 10. Dalakas MC. Current treatment of the inflammatory myopathies. Curr Opin Rheumatol 1994;6:595-601.
11. 11. Kasteler JS, Callen JP. Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. J Am Acad Dermatol 1997;36:67-71.
12. 12. Zieglschmid-Adams ME, Pandya AF, Cohen SB, Sontheimer RD. The value of methotrexate in dermatomyositis. J Am Acad Dermatol 1998;38:131-2.
13. 13. Maeda K, Kimura R, Komuta K, Igarashi T. Cyclosporine treatment for polymyositis/dermatomyositis: Is it possible to rescue the deteriorating cases with interstitial pneumonitis?. Scand J Rheumatol 1997;26:24-9.
14. 14. Hamill G, Saunders C, Heckmatt J, Dubowitz V, Stanhope R. "Catch-up" growth in steroid dependent dermatomyositis treated with cyclosporine-A. Eur J Med 1992;1:16-8.
15. 15. Zeller V, Cohen P, Prieur AM, Guillevin L. Cyclosporine A therapy in refractory juvenile dermatomyositis. Experience and long-term follow-up of 6 cases. J Rheumatol 1996; 23:1424-7.
16. 16. Reiff A, Rawlings DJ, Shaham B, Franke E, Richardson L, Szer IS, et al. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. J Rheumatol 1997; 24:2436-43.
17. 17. Saadeh C, Bridges W, Burwick F. Dermatomyositis: remission induced with combined oral cyclosporine and high-dose intravenous immune globulin. South Med J 1995;88:866-70.
18. 18. Zabel P, Leimenstoll G, Gross WL. Cyclosporin for acute dermatomyositis. Lancet 1984;i:343.
19. 19. Alijotas J, Barquinero J, Ordi J, Vilardell M. Polymyositis and cyclosporine A. Ann Rheum Dis 1990;49:66.
20. 20. Lueck CJ, Trend P, Swash M. Cyclosporine in the management of polymyositis and dermatomyositis. J Neurol Neurosurg Psychiatry 1991;54:1007-8.
21. 21. Gruhn WB, Diaz-Buxo JA. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermalomyositis/polymyositis. J Rheumatol 1987;14:1045-7.
22. 22. Mehregan DR, Su WP. Cyclosporine treatment for dermatomyositis/polymyositis. Cutis 1993;51:59-61.
23. 23. Pistoia V, Buoncompagni A, Scribanis R, Fasce L, Alpigiani G, Cordone G, et al. Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Results of a preliminary study. Clin Exp Rheumatol 1993;11:203-8.
24. 24. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
25. 25. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
26. 26. Josefson A, Romanus E, Carlsson J. A functional index in myositis. J Rheumatol 1996;23:1380-4.
27. 27. Hernandez RJ, Keim DR, Chenevert TL, Sullivan DB, Aisen AM. Fat-suppressed MR imaging of myositis. Radiology 1992;182:217-9.
28. 28. Vencovský J, Jarošová K, Charvát F. The use of magnetic resonance in diagnostics and activity assessment of idiopathic inflammatory myopathies (In Czech). Ces Revmatol 1997; 5:163-168.
29. 29. van Venrooij WJ, Maini RN, eds. Manual of Biological Markers of Disease. Dordrecht, Boston, London: Kluwer Academic Publishers, 1993.
30. 30. Vencovský J, Kafková J, Štork J, Dostál C. Antinuclear and anticytoplasmic autoantibodies in systemic rheumatic diseases - the use of immunoblotting detection (In Czech). Ces Revmatol 1997;5:71-81.
31. 31. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patients groups. Medicine 1991; 70:360-73.
32. 32. Sauty A, Rochat T, Schoch OD, Hamacher J, Kurt AM, Dayer JM, et al. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J 1997;10:2907-12.
33. 33. Feutren G, Mihatsch MJ. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992;326:1654-60.
34. 34. Zachariae H. Renal toxicity of long-term ciclosporin. Scand J Rheumatol 1999;28:65-8.
35. 35. Tugwell P, Pincus T, Yocum D, Stein M, Gluck O, Kraag G, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995;333:137-41.
36. 36. Gabay C, Gay-Croisier F, Roux-Lombard P, Meyer O, Maineti C, Guerne PA, et al. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. Arthritis Rheum 1994;37:1744-51.
37. 37. Prieur AM, Dayer A, Roux-Lombard P, Dayer JM. Levels of cytokine inhibitors: A possible marker of disease activity in childhood dermatomyositis and polymyositis. Clin Exp Rheumatol 1997;15:211-4.